Literature DB >> 22521466

Creatine pretreatment protects cortical axons from energy depletion in vitro.

Hua Shen1, Mark P Goldberg.   

Abstract

Creatine is a natural nitrogenous guanidino compound involved in bioenergy metabolism. Although creatine has been shown to protect neurons of the central nervous system (CNS) from experimental hypoxia/ischemia, it remains unclear if creatine may also protect CNS axons, and if the potential axonal protection depends on glial cells. To evaluate the direct impact of creatine on CNS axons, cortical axons were cultured in a separate compartment from their somas and proximal neurites using a modified two-compartment culture device. Axons in the axon compartment were subjected to acute energy depletion, an in vitro model of white matter ischemia, by exposure to 6mM sodium azide for 30 min in the absence of glucose and pyruvate. Energy depletion reduced axonal ATP by 65%, depolarized axonal resting potential, and damaged 75% of axons. Application of creatine (10 mM) to both compartments of the culture at 24h prior to energy depletion significantly reduced axonal damage by 50%. In line with the role of creatine in the bioenergy metabolism, this application also alleviated the axonal ATP loss and depolarization. Inhibition of axonal depolarization by blocking sodium influx with tetrodotoxin also effectively reduced the axonal damage caused by energy depletion. Further study revealed that the creatine effect was independent of glial cells, as axonal protection was sustained even when creatine was applied only to the axon compartment (free from somas and glial cells) for as little as 2h. In contrast, application of creatine after energy depletion did not protect axons. The data provide the first evidence that creatine pretreatment may directly protect CNS axons from energy deficiency.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22521466      PMCID: PMC3367034          DOI: 10.1016/j.nbd.2012.03.037

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  67 in total

1.  Ion transport and membrane potential in CNS myelinated axons. II. Effects of metabolic inhibition.

Authors:  L Leppanen; P K Stys
Journal:  J Neurophysiol       Date:  1997-10       Impact factor: 2.714

2.  PDMS absorption of small molecules and consequences in microfluidic applications.

Authors:  Michael W Toepke; David J Beebe
Journal:  Lab Chip       Date:  2006-10-04       Impact factor: 6.799

3.  A microfluidic culture platform for CNS axonal injury, regeneration and transport.

Authors:  Anne M Taylor; Mathew Blurton-Jones; Seog Woo Rhee; David H Cribbs; Carl W Cotman; Noo Li Jeon
Journal:  Nat Methods       Date:  2005-08       Impact factor: 28.547

4.  The role of creatine kinase in inhibition of mitochondrial permeability transition.

Authors:  E O'Gorman; G Beutner; M Dolder; A P Koretsky; D Brdiczka; T Wallimann
Journal:  FEBS Lett       Date:  1997-09-08       Impact factor: 4.124

5.  Exogenous creatine delays anoxic depolarization and protects from hypoxic damage: dose-effect relationship.

Authors:  M Balestrino; R Rebaudo; G Lunardi
Journal:  Brain Res       Date:  1999-01-16       Impact factor: 3.252

6.  Local control of neurite development by nerve growth factor.

Authors:  R B Campenot
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

7.  Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation.

Authors:  Max Dolder; Bernd Walzel; Oliver Speer; Uwe Schlattner; Theo Wallimann
Journal:  J Biol Chem       Date:  2003-03-05       Impact factor: 5.157

8.  Improved reperfusion and neuroprotection by creatine in a mouse model of stroke.

Authors:  Konstantin Prass; Georg Royl; Ute Lindauer; Dorette Freyer; Dirk Megow; Ulrich Dirnagl; Gerda Stöckler-Ipsiroglu; Theo Wallimann; Josef Priller
Journal:  J Cereb Blood Flow Metab       Date:  2006-06-14       Impact factor: 6.200

9.  Hypoxic injury of isolated axons is independent of ionotropic glutamate receptors.

Authors:  Suzanne M Underhill; Mark P Goldberg
Journal:  Neurobiol Dis       Date:  2006-10-27       Impact factor: 5.996

10.  Effects of accumulation of phosphocreatine on the survival time of thin hippocampal slices from the guinea pig during deprivation of both oxygen and glucose.

Authors:  Y Okada; K Yoneda
Journal:  Neurosci Lett       Date:  1983-10-31       Impact factor: 3.046

View more
  11 in total

1.  Creatine supplementation enhances corticomotor excitability and cognitive performance during oxygen deprivation.

Authors:  Clare E Turner; Winston D Byblow; Nicholas Gant
Journal:  J Neurosci       Date:  2015-01-28       Impact factor: 6.167

Review 2.  Creatine as a Neuroprotector: an Actor that Can Play Many Parts.

Authors:  Eduardo Peil Marques; Angela T S Wyse
Journal:  Neurotox Res       Date:  2019-05-08       Impact factor: 3.911

3.  Maintaining energy homeostasis is an essential component of Wld(S)-mediated axon protection.

Authors:  Hua Shen; Krzysztof L Hyrc; Mark P Goldberg
Journal:  Neurobiol Dis       Date:  2013-07-24       Impact factor: 5.996

4.  Cardiovascular risks impact human brain N-acetylaspartate in regionally specific patterns.

Authors:  Joshua Chiappelli; Laura M Rowland; S Andrea Wijtenburg; Hongji Chen; Andrew A Maudsley; Sulaiman Sheriff; Shuo Chen; Anya Savransky; Wyatt Marshall; Meghann C Ryan; Heather A Bruce; Alan R Shuldiner; Braxton D Mitchell; Peter Kochunov; L Elliot Hong
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-21       Impact factor: 11.205

Review 5.  Of axons that struggle to make ends meet: Linking axonal bioenergetic failure to programmed axon degeneration.

Authors:  Elisabetta Babetto; Bogdan Beirowski
Journal:  Biochim Biophys Acta Bioenerg       Date:  2022-03-23       Impact factor: 4.428

6.  The axon-protective WLD(S) protein partially rescues mitochondrial respiration and glycolysis after axonal injury.

Authors:  Katharina Godzik; Michael P Coleman
Journal:  J Mol Neurosci       Date:  2014-10-29       Impact factor: 3.444

Review 7.  Metabolic Vulnerability in the Neurodegenerative Disease Glaucoma.

Authors:  Denise M Inman; Mohammad Harun-Or-Rashid
Journal:  Front Neurosci       Date:  2017-03-30       Impact factor: 4.677

8.  The cellular and compartmental profile of mouse retinal glycolysis, tricarboxylic acid cycle, oxidative phosphorylation, and ~P transferring kinases.

Authors:  Elda M Rueda; Jerry E Johnson; Anand Giddabasappa; Anand Swaroop; Matthew J Brooks; Irena Sigel; Shawnta Y Chaney; Donald A Fox
Journal:  Mol Vis       Date:  2016-07-23       Impact factor: 2.367

Review 9.  Important roles of dietary taurine, creatine, carnosine, anserine and 4-hydroxyproline in human nutrition and health.

Authors:  Guoyao Wu
Journal:  Amino Acids       Date:  2020-02-18       Impact factor: 3.789

Review 10.  Differences Between Human and Murine Tau at the N-terminal End.

Authors:  Félix Hernández; Jesús Merchán-Rubira; Laura Vallés-Saiz; Alberto Rodríguez-Matellán; Jesús Avila
Journal:  Front Aging Neurosci       Date:  2020-01-28       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.